Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Alzheimer's disease severely compromises cognitive function. One of the mechanisms to explain the pathology of Alzheimer's disease has been the hypotheses of amyloid-pore/channel formation by complex Aβ-aggregates. Clinical studies suggested the moderate alcohol consumption can reduces probability developing neurodegenerative pathologies. A recent report explored the ability of ethanol to disrupt the generation of complex Aβ in vitro and reduce the toxicity in two cell lines. Molecular dynamics simulations were applied to understand how ethanol blocks the aggregation of amyloid. On the other hand, the in silico modeling showed ethanol effect over the dynamics assembling for complex Aβ-aggregates mediated by break the hydrosaline bridges between Asp 23 and Lys 28, was are key element for amyloid dimerization. The amyloid pore/channel hypothesis has been explored only in neuronal models, however recently experiments suggested the frog oocytes such an excellent model to explore the mechanism of the amyloid pore/channel hypothesis. So, the used of frog oocytes to explored the mechanism of amyloid aggregates is new, mainly for amyloid/pore hypothesis. Therefore, this experimental model is a powerful tool to explore the mechanism implicates in the Alzheimer's disease pathology and also suggests a model to prevent the Alzheimer's disease pathology.
Fig. 1. Model effect of ethanol in aggregation process, oocytes membrane use for pharmacological solution exploration. The model, show the summary of Aβ-aggregate review, in the right upper panel, the effect of the ethanol in the aggregation process, left panel show the Aβ-aggregate effect over synapsis in particular over presynaptic membrane. The lower panel presents the use of oocytes for explored Aβ-aggregate effect, pore formation and future research in easy membrane model.
Alarcón,
Ion channel formation by Alzheimer's disease amyloid beta-peptide (Abeta40) in unilamellar liposomes is determined by anionic phospholipids.
2006, Pubmed
Alarcón,
Ion channel formation by Alzheimer's disease amyloid beta-peptide (Abeta40) in unilamellar liposomes is determined by anionic phospholipids.
2006,
Pubmed
Anstey,
Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies.
2009,
Pubmed
Arispe,
Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers.
2007,
Pubmed
Arispe,
Architecture of the Alzheimer's A beta P ion channel pore.
2004,
Pubmed
Arispe,
The ability of amyloid beta-protein [A beta P (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer's disease.
1994,
Pubmed
Bell,
Altered synaptic function in Alzheimer's disease.
2006,
Pubmed
Bernareggi,
Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes.
2007,
Pubmed
Bourin,
Nicotinic receptors and Alzheimer's disease.
2003,
Pubmed
Bush,
Rapid induction of Alzheimer A beta amyloid formation by zinc.
1994,
Pubmed
Clark,
Toxicity of beta-amyloid25-35 peptide in PC12 cells.
1993,
Pubmed
Collins,
Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms.
2010,
Pubmed
Connelly,
Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.
2012,
Pubmed
Cornejo,
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease.
2011,
Pubmed
Demuro,
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.
2005,
Pubmed
Demuro,
Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology.
2011,
Pubmed
,
Xenbase
Demuro,
Cytotoxicity of intracellular aβ42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate.
2013,
Pubmed
,
Xenbase
Ding,
Direct observation of protein folding, aggregation, and a prion-like conformational conversion.
2005,
Pubmed
Edelstein-keshet,
Exploring the formation of Alzheimer's disease senile plaques in silico.
2002,
Pubmed
Glabe,
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis.
2006,
Pubmed
Gundersen,
Choline acetyltransferase and acetylcholine in Xenopus oocytes injected with mRNA from the electric lobe of Torpedo.
1985,
Pubmed
,
Xenbase
Haass,
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.
2007,
Pubmed
Ho,
Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration.
2009,
Pubmed
Jang,
Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process.
2007,
Pubmed
Kang,
Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death.
2011,
Pubmed
Kawahara,
Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line.
2000,
Pubmed
Kawahara,
Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons.
1997,
Pubmed
Kim,
Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult.
2007,
Pubmed
Kourie,
Diversity of amyloid beta protein fragment [1-40]-formed channels.
2001,
Pubmed
Lacor,
Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
2004,
Pubmed
Lührs,
3D structure of Alzheimer's amyloid-beta(1-42) fibrils.
2005,
Pubmed
Mattson,
Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
2001,
Pubmed
Mattson,
Pathways towards and away from Alzheimer's disease.
2004,
Pubmed
Miledi,
Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes.
2004,
Pubmed
,
Xenbase
Morrill,
Progesterone release of lipid second messengers at the amphibian oocyte plasma membrane: role of ceramide in initiating the G2/M transition.
1998,
Pubmed
,
Xenbase
Mosa,
Members of rice plasma membrane intrinsic proteins subfamily are involved in arsenite permeability and tolerance in plants.
2012,
Pubmed
,
Xenbase
Nishimura,
Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer.
1998,
Pubmed
Noor,
Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers.
2012,
Pubmed
Oddo,
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.
2006,
Pubmed
Orgogozo,
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
1997,
Pubmed
Ormeño,
Ethanol reduces amyloid aggregation in vitro and prevents toxicity in cell lines.
2013,
Pubmed
Parodi,
Functional and structural effects of amyloid-β aggregate on Xenopus laevis oocytes.
2012,
Pubmed
,
Xenbase
Parodi,
Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure.
2010,
Pubmed
Peters,
Alcohol, dementia and cognitive decline in the elderly: a systematic review.
2008,
Pubmed
Prangkio,
Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity.
2012,
Pubmed
Quist,
Amyloid ion channels: a common structural link for protein-misfolding disease.
2005,
Pubmed
Rowan,
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
2005,
Pubmed
Russo,
Red wine micronutrients as protective agents in Alzheimer-like induced insult.
2003,
Pubmed
Scarmeas,
Mediterranean diet and Alzheimer disease mortality.
2007,
Pubmed
Schmidt,
Voltage-dependent K+ channel gating and voltage sensor toxin sensitivity depend on the mechanical state of the lipid membrane.
2008,
Pubmed
,
Xenbase
Sepulveda,
Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property.
2010,
Pubmed
Sepúlveda,
Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer's disease.
2014,
Pubmed
Simakova,
The cell-selective neurotoxicity of the Alzheimer's Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity.
2007,
Pubmed
Stöckl,
α-Synuclein oligomers: an amyloid pore? Insights into mechanisms of α-synuclein oligomer-lipid interactions.
2013,
Pubmed
Sun,
The "French Paradox" and beyond: neuroprotective effects of polyphenols.
2002,
Pubmed
Uc,
Driving and neurodegenerative diseases.
2008,
Pubmed
Uetsuki,
Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein.
1999,
Pubmed
Walsh,
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
2002,
Pubmed
Wang,
Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model.
2011,
Pubmed
Wang,
Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease.
2006,
Pubmed
Wood,
Brain membrane cholesterol domains, aging and amyloid beta-peptides.
2002,
Pubmed
Yankner,
Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease.
2009,
Pubmed
Yevenes,
Modulation of glycine-activated ion channel function by G-protein betagamma subunits.
2003,
Pubmed
Zhao,
Molecular dynamics simulations of low-ordered alzheimer β-amyloid oligomers from dimer to hexamer on self-assembled monolayers.
2011,
Pubmed
Zhu,
Fresh and nonfibrillar amyloid beta protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbetaP-channel-mediated cellular toxicity.
2000,
Pubmed
Ziegler-Graham,
Worldwide variation in the doubling time of Alzheimer's disease incidence rates.
2008,
Pubmed
